UK Licensed & Regulated Pharmacy
MHRA Compliant Medication
Privacy Assured
Images Are For Illustration Purposes Only

Wegovy Oral Tablets

4.7 out of 5 on Trustpilot

Wegovy Oral Pill is an upcoming weight management treatment containing semaglutide, the same active ingredient used in Wegovy injection. It belongs to a group of medicines called GLP-1 receptor agonists, which work by helping you feel fuller for longer, reducing appetite, and supporting healthier food choices.

This product is intended to support adults living with obesity, or adults who are overweight with weight-related health concerns, when used alongside a reduced-calorie diet and increased physical activity.

Please note: this page is currently for testing purposes only. Full product information, availability, suitability criteria, and prescribing guidance will be updated once confirmed.

From £149.00
Only £4.97 per tablet!
UK Licensed & Regulated Pharmacy
MHRA Compliant Medication
Privacy Assured
Images Are For Illustration Purposes Only
Other Options Include

A new version of Wegovy should arrive in the UK soon. Patients will have a convenient alternative to weekly weight loss injections.

Wegovy Tablets contain Semaglutide, the same active ingredient used in Wegovy injections, but in a once-daily tablet. For many patients, this could be a more flexible and convenient option. It helps them access a highly effective weight loss medication.

At IQ Doctor, we're expecting significant interest when Wegovy Tablets become available. Register your interest today and be among the first to hear about availability, pricing and prescribing updates.

What Are Wegovy Tablets?

Wegovy Tablets contain Semaglutide, a GLP-1 receptor agonist that helps regulate appetite and support weight loss.

Semaglutide works by mimicking a naturally occurring hormone that helps control hunger and food intake. This can help patients feel fuller for longer, reduce food cravings and consume fewer calories throughout the day.

When used with a reduced-calorie diet and more physical activity, oral Semaglutide can help with weight loss. It can also support long-term weight management.

Why Are Patients Excited About Wegovy Tablets?

The launch of Wegovy tablets could be a major step forward in medical weight management. It could be the biggest advance since GLP-1 weight loss injections.

No Injections Required

Many patients are interested in Semaglutide treatment but would prefer not to use injections.

For many patients who are needle phobic the idea of injecting themselves weekly can feel overwhelming.

For other patients, there is a psychological barrier. Many are used to taking tablets, but injections feel outside their comfort zone.

Some patients want more control. Tablets can be taken daily and adjusted. Injectables set your dose for the week.

Wegovy Tablets offer a convenient daily alternative without the need for needles, injection pens or sharps disposal.

No Refrigeration Needed

Unlike many injectable treatments, Wegovy Tablets do not require cold-chain storage.

This means:

  • No refrigeration during transport
  • Easier storage at home
  • Greater flexibility for travel
  • Convenient delivery and handling

It also means packaging costs stay low. There is no longer a need for large, bulky postage with thermal wool and ice packs. This cuts waste and makes deliveries easier to receive.

Ideal for Travel

Whether you’re travelling for work, going on holiday, or managing a busy lifestyle, tablets are easy to carry. They are also discreet to take.

Carrying sharps and needles through the airport can be daunting let alone the hassle of ice packs and cool boxes. With the new oral tablets there's no need to pack injection pens, cooling packs or sharps bins.

Long Shelf Life

Wegovy Tablets may have a shelf life of up to three years if stored properly. This makes them convenient for long-term treatment and travel.

Convenient Monthly Packs

Treatment will come in packs of 30 tablets. This provides a one-month supply in a simple, easy-to-manage format.

How Does Oral Semaglutide Help With Losing Weight?

Oral Semaglutide works by targeting appetite regulation pathways within the body.

This can help patients:

  • Feel fuller after meals
  • Reduce food noise
  • Experience fewer food cravings
  • Consume fewer calories
  • Develop healthier eating habits

Semaglutide is not a stimulant. It supports natural appetite control. This helps patients keep a reduced-calorie diet long term.

What Do Clinical Trials Show?

Clinical trials of oral semaglutide have shown promising results for both weight loss and overall metabolic health.

In the OASIS 4 phase 3 clinical trial, adults living with obesity or overweight taking oral semaglutide 25mg achieved an average weight loss of around 16.6% over the study period when combined with a reduced calorie diet and increased physical activity.

A significant proportion of participants lost 20% or more of their body weight, highlighting the potential effectiveness of this treatment when used as part of a structured weight management programme.

The study also observed improvements in several health markers linked to weight related health conditions, including blood sugar control and cardiovascular risk factors. In participants with prediabetes at the start of the trial, more than 70% experienced a return to normal blood glucose levels during treatment.

These results suggest that oral semaglutide may support not only losing weight, but also broader improvements in long term metabolic health.

As with all weight loss medication, individual results can vary depending on lifestyle, adherence and starting weight.

Expected Dosing Schedule

Wegovy Tablets are expected to be available in four strengths:

  • 1.5mg
  • 4mg
  • 9mg
  • 25mg maintenance dose

Patients will typically begin treatment at a lower dose before gradually increasing to higher strengths over time. This approach helps minimise side effects and allows the body to adjust to treatment.

Each pack is expected to contain 30 tablets.

Why are dosages so different to the injectables?

Medication that is administered via a subcutaneous injection, such as Wegovy, is delivered under the skin where it is absorbed more directly into the bloodstream. Because of this route of administration, a greater proportion of the active ingredient enters the circulation, meaning lower doses are required compared with oral formulations.

In contrast, when taking medication orally, the active ingredient (semaglutide) must first pass through the digestive system. It needs to withstand stomach acid and the breakdown processes of the gut before it can be absorbed into the bloodstream. During this process, only a portion of the dose is able to reach the circulation.

For this reason, oral semaglutide tablets contain a higher amount of the active ingredient than injectable treatments, in order to reach those higher levels of weight loss and achieve the intended therapeutic effect.

However, this difference in absorption is also what enables a key advantage of the oral formulation — offering patients a clinically familiar treatment pathway in a simple daily tablet, combining established efficacy with a more flexible and accessible way to support long-term weight management.

What is this likely to cost?

Formal prices have not yet been released by NovoNordisk but prices are likely to stay in line with current treatments. Although the tablets need more active ingredient, they also reduce injection costs. They also cut delivery and storage costs.

This lets us pass the savings on to our patients.

Will I be required to start over again?

There will likely be switching guidance released soon by IQDoctor, this will allow patients to switch seamlessly from one weight loss medication to another. Before making the switch from injectable to oral medication there may be some clinical implications. To learn more about the latest medications and how to use them consider signing up to our email list.

Who May Be Eligible?

Wegovy Tablets may be suitable for adults who meet the prescribing criteria for medical weight management.

This may include patients with:

  • A Body Mass Index (BMI) of 30 kg/m² or above
  • A Body Mass Index (BMI) of 27 kg/m² or above with a weight related health condition

Examples of weight related health conditions include:

  • High blood pressure
  • High cholesterol
  • Sleep apnoea
  • Cardiovascular disease
  • Type 2 diabetes

All patients will require assessment by a healthcare professional before treatment can be prescribed.

Can Semaglutide Also Treat Type 2 Diabetes?

Semaglutide has been used for several years to treat type 2 diabetes in different formulations.

However, Wegovy Tablets are expected to be prescribed specifically for weight management and losing weight in eligible patients.

Your healthcare professional will determine the most appropriate treatment based on your medical history and treatment goals.

Important Safety Information

Like all medicines, Wegovy Tablets can cause side effects.

Common side effects may include:

  • Nausea
  • Vomiting
  • Diarrhoea
  • Constipation
  • Stomach discomfort

Patients should read the Patient Information Leaflet carefully before starting treatment.

Seek medical advice immediately if you experience symptoms of an allergic reaction or any severe or unexpected side effects.

Regulatory Approval and Availability

All prescription medicines supplied in the UK must be authorised by the Medicines and Healthcare Products Regulatory Agency (MHRA).

Guidance relating to weight loss medication may also be reviewed by the National Institute for Health and Care Excellence (NICE).

We are closely monitoring updates from the Medicines and Healthcare Products Regulatory Agency and will provide further information as soon as UK availability is confirmed.

We know many people on social media pose as health gurus. They offer Wegovy, Mounjaro, and even Retatrutide without any verification process.

Often medication intended for "research purposes only" are being sold to patients unwittingly. We urge all our patients to seek medication from trusted sources online. Medication "fakes" can lead to serious health consequences.

Be Among the First to Hear About Wegovy Tablets

Demand for Wegovy Tablets is expected to be high when prescribing begins.

By joining our waiting list, you'll be among the first to:

  • Receive launch updates
  • Hear about availability and pricing
  • Access clinical guidance
  • Stay informed about the latest treatment developments

If you want a simple daily Semaglutide tablet with similar weight loss benefits to Wegovy injections, register today. Be among the first to hear when it becomes available in the UK.